DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB16277
| null |
Paltusotine
|
2172870-89-0
|
F2IBD1GMD3
|
Paltusotine
|
GHILNKWBALQPDP-UHFFFAOYSA-N
|
DB16278
| null |
Parathyroid Hormone-Related Protein 1-36
|
172867-62-8
|
42VQY191QQ
|
1-36 hpthrp | 1-36 human humoral hypercalcemic factor | 1-36 human parathyroid hormone-related protein | Parathormone-related peptide (1-36) (human) | Parathyroid hormone related protein (1-36) | Parathyroid hormone related protein(1-36) | Parathyroid hormone-related protein 1-36
| null |
DB16279
| null |
Pecavaptan
|
1914998-56-3
|
44Q500OSL4
|
Pecavaptan
|
AZXOTZCWQDJCLY-SJCJKPOMSA-N
|
DB16280
| null |
Pegcantratinib
|
1233363-33-1
|
VG44NU1168
|
Pegcantratinib
| null |
DB16281
| null |
Pegcrisantaspase
|
1448590-54-2
|
Y8KTZ6Y35U
|
Asparec | mPEG-R-Crisantaspase | Pegcrisantaspase | Pegylated dickeya chrysanthemi l-asparaginase | Pegylated erwinia chrysanthemi l-asparaginase | POLYETHYLENE-GLYCOL-ERWINIA-CHRISANTHEMI-L-ASPARAGINASE
| null |
DB16282
| null |
Pegylated Recombinant Human Arginase I
|
1433787-75-7
|
S3HC6XX81X
|
Pegylated recombinant human arginase i bct-100
| null |
DB16283
| null |
Pegylated synthetic human c-peptide
|
1350661-05-0
|
IF95YG4W0P
|
Ersatta | Pegylated human c-peptide
| null |
DB16284
| null |
Pelacarsen
|
1637637-70-7
|
LSO9H7UZ90
|
AKCEA-APO(a)-LRx | IONIS-APO(a)-LRx | Isis-681257 (galnac3--conjugated aso targeting human lipoprotein (a)) free acid | Pelacarsen
| null |
DB16285
| null |
Pelcitoclax
|
1619923-36-2
|
317UBD60ML
|
Pelcitoclax
|
QIOCQCYXBYUYLH-YACUFSJGSA-N
|
DB16286
| null |
Pemlimogene merolisbac
| null |
S2EGO8116S
|
Ladd listeria monocytogenes jnj-64041757 | Live-attenuated listeria monocytogenes encoding egfrviii-mesothelin vaccine jnj-64041757 | Pemlimogene merolisbac | Recombinant live-attenuated double-deleted (ladd) strain of listeria monocytogenes (lm .delta.acta/.delta.inlb) expressing a fusion protein comprising the n-terminal 100 amino acids of the lm acta protein (actan100), 5 tandem copies of a 21 amino acid fr
| null |
DB16287
| null |
Penequinine, Penehyclidine
|
87827-02-9
|
353CX8CSHD
|
Penehyclidine | Penequine | Penequinine | Penethequinine
|
GTKRIWMDLNOSLI-UHFFFAOYSA-N
|
DB16288
| null |
Peoniflorin
|
23180-57-6
|
21AIQ4EV64
|
Paeoniflorin
|
YKRGDOXKVOZESV-WRJNSLSBSA-N
|
DB16289
| null |
B27PD
|
160387-12-2
|
D99LD4BK0S
|
Alnedlsswtaadt | Optiquel | Peptide b27pd
| null |
DB16290
| null |
DAPTA
|
106362-34-9
|
J208V4ZMP2
|
Adaptavir | Peptide t amide, 1(d-ala)
|
AKWRNBWMGFUAMF-ZESMOPTKSA-N
|
DB16291
| null |
Peretinoin
|
81485-25-8
|
11ALM7A4RV
|
Peretinoin
|
UUBHZHZSIKRVIV-KCXSXWJSSA-N
|
DB16292
| null |
Perfluorodecalin
|
306-94-5
|
54A06VV62N
|
Acri-deca | Fluosol da perfluorodecalin | Octadecafluorodecahydronaphthalene | Perflunafene | Perfluorodecalin | Perftoran component perfluorodecalin
|
UWEYRJFJVCLAGH-UHFFFAOYSA-N
|
DB16293
| null |
Pexiganan
|
147664-63-9
|
TVF29Q70Q1
|
Pexiganan
| null |
DB16294
| null |
Pexmetinib
|
945614-12-0
|
3750D0U8B5
|
Pexmetinib
|
LNMRSSIMGCDUTP-UHFFFAOYSA-N
|
DB16295
| null |
HSK-3486
|
1637741-58-2
|
M3WGS532VY
| null |
BMEARIQHWSVDBS-SNVBAGLBSA-N
|
DB16296
| null |
IPI-549
|
1693758-51-8
|
FOF5155FMZ
|
Pi3k-gamma inhibitor ipi-549
|
XUMALORDVCFWKV-IBGZPJMESA-N
|
DB16297
| null |
Florzolotau F-18
|
1565797-57-0
|
51M993JIQ4
| null |
XXNYLYXTRMQXJS-CDLXMPELSA-N
|
DB16298
| null |
Polifeprosan 20
|
90409-78-2
|
S40C40DA21
|
Polifeprosan | Polifeprosan 20
| null |
DB16299
| null |
Poseltinib
|
1353552-97-2
|
D01E4B1U35
|
Poseltinib
|
LZMJNVRJMFMYQS-UHFFFAOYSA-N
|
DB16300
| null |
Praliciguat
|
1628730-49-3
|
R1S0H458SA
|
Praliciguat
|
CYSJNTQNMDWAJV-UHFFFAOYSA-N
|
DB16301
| null |
Preimplantation factor
|
485818-40-4
|
3K6A6FJ98O
|
Synthetic PreImplantation Factor
|
GLXYOFXNKBTMQL-YKCHQESGSA-N
|
DB16302
| null |
BP-14979
|
1000036-77-0
|
XN7HA74WB0
| null |
PLMAPPWZOQMTBI-XUTJKUGGSA-N
|
DB16303
| null |
Gallium-68 PSMA
|
1366302-52-4
|
9AG41L3AOQ
|
Psma-hbed-cc
|
QJUIUFGOTBRHKP-LQJZCPKCSA-N
|
DB16304
| null |
TAK-653
|
1358751-06-0
|
9E3TOE5RIZ
| null |
PXJBHEHFVQVDDS-UHFFFAOYSA-N
|
DB16305
| null |
Xevinapant
|
1071992-99-8
|
N65WC8PXDD
|
(5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide | Iap inhibitor at-406 | PYRROLO(1,2-A)(1,5)DIAZOCINE-8-CARBOXAMIDE, N-(DIPHENYLMETHYL)DECAHYDRO-5-(((2S)-2-(METHYLAMINO)-1-OXOPROPYL)AMINO)-3-(3-METHYL-1-OXOBUTYL)-6-OXO-, (5S,8S,10AR)- | Xevinapant
|
LSXUTRRVVSPWDZ-MKKUMYSQSA-N
|
DB16306
| null |
Racemetyrosine
|
658-48-0
|
X88TTO174Z
|
AMPT | D,L-metyrosine | DL-metyrosine | Racemetirosina | Racemetirosine | Racemetirosinum | Racemetyrosine | Sm-88 component racemetyrosine
|
NHTGHBARYWONDQ-UHFFFAOYSA-N
|
DB16307
| null |
A-dmDT390-bisFv(UCHT1)
|
1470038-56-2
|
P7MQ9ZOQ82
|
Anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | Recombinant anti-cdr-bi-single-chain-fv-diphtheria toxin fusion protein | Recombinant anti-cdr-bi-single-chain-fv-diptheria toxin fusion protein | Resimmune
| null |
DB16308
| null |
Revaprazan
|
199463-33-7
|
5P184180P5
|
Revaprazan | Yh-1885 free base
|
LECZXZOBEZITCL-UHFFFAOYSA-N
|
DB16309
| null |
Revusiran
|
1438322-82-7
|
ZE6EHM8Z3A
|
Revusiran
| null |
DB16310
| null |
Rezafungin
|
1396640-59-7
|
G013B5478J
|
Biafungin | Echinocandin B, 1-((4R,5R)-4-hydroxy-N2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-5-(2-(trimethylammonio)ethoxy)-l-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxyphenyl)-l-allothreonine)- | Rezafungin | Rezafungin cation | Rezafungin ion
|
LNFCWEXGZIEGJW-TXSVMFMRSA-O
|
DB16311
| null |
Ribaxamase
|
1792207-66-9
|
6A002O1K0R
|
.beta.-lactamase (synthetic bacillus licheniformis isoenzyme syn-004) | Ribaxamase
| null |
DB16312
| null |
TNP-2092
|
922717-97-3
|
W2P7EF7O6O
| null |
OPZFMLLAJBIKAN-JNEXSVMGSA-N
|
DB16313
| null |
Rinucumab
|
1569263-06-4
|
10E3O6YI4W
|
Immunoglobulin g4, anti-(human platelet-derived growth factor receptor~) (human monoclonal regn2176 heavy chain), disulfide with human monoclonal regn2176 k-chain, dimer | Rinucumab
| null |
DB16314
| null |
Ripertamab
|
2249927-04-4
|
URS0374MIV
|
Immunoglobulin g1-kappa, anti-(homo sapiens ms4a1 (membrane-spanning 4-domains subfamily a member 1, cd20)), chimeric monoclonal antibody | Immunoglobulin igg1, anti-(human cd20 antigen) (human-mus musculus monoclonal disulfide sct400 .gamma.1-chain), disulfide with human-mus musculus monoclonal sct400 .kappa.-chain, dimer | Ripertamab
| null |
DB16315
| null |
Rivenprost
|
256382-08-8
|
1WBO45T413
|
Rivenprost
|
FBQUXLIJKPWCAO-AZIFJQEOSA-N
|
DB16316
| null |
Rocakinogene sifuplasmid
|
2253753-17-0
|
91JHE0ANN8
|
Rocakinogene sifuplasmid
| null |
DB16317
| null |
Roledumab
|
1174008-79-7
|
Z4T52O86QV
|
Immunoglobulin g1-kappa, anti-(homo sapiens rhd(rhesus blood group d antigen, rhd, cd240d)), homo sapiens monoclonal antibody | Roledumab
| null |
DB16318
| null |
Romilkimab
|
1399584-78-1
|
O8HNJ174XS
|
Bispecific antibody targeting interleukin 4 (IL-4) and interleukin 13 (IL-13) | Hutbti3_2_1 | Romilkimab
| null |
DB16319
| null |
GSK-2981278
|
1474110-21-8
|
L49V5G013I
|
Ror gama modulator 1
|
LZLBRISQTJVZNP-UHFFFAOYSA-N
|
DB16320
| null |
Rovazolac
|
1454288-88-0
|
W51K389XIL
|
Rovazolac
|
ZUMNJDGBYXHASJ-UHFFFAOYSA-N
|
DB16321
| null |
S-777469
|
885496-53-7
|
88NI79737I
| null |
JIYXOJFSPOFZPY-UHFFFAOYSA-N
|
DB16322
| null |
Sabatolimab
|
2252262-24-9
|
3L7R886Y06
|
Anti-tim-3 monoclonal antibody mbg453 | Anti-tim3 checkpoint inhibitor mbg453 | Immunoglobulin g4 (226-proline,de-c-terminal-lysine), anti-(human hepatitis virus a cellular receptor 2) (human-mus musculus monoclonal clone nvs260714 .gamma.4-chain), disulfide with human-mus musculus monoclonal clone nvs260714 .kappa.-chain, dimer | Immunoglobulin g4-kappa, anti-(homo sapiens havcr2 (hepatitis a virus cellular receptor 2, t-cell immunoglobulin mucin family member 3, tim-3, tim3, timd3, cd366)), humanized monoclonal antibody | Sabatolimab
| null |
DB16323
| null |
Satoreotide tetraxetan
|
1039726-31-2
|
EC1O2FB9FV
|
Dota satoreotide | Satoreotide dota | Satoreotide tetraxetan
|
ZJZDXGQUNVNYQP-PBJKGYOGSA-N
|
DB16324
| null |
Selgantolimod
|
2004677-13-6
|
RM4GJT3SMQ
|
Selgantolimod
|
HTCJUBZBSJQWBW-AWEZNQCLSA-N
|
DB16325
| null |
Selodenoson
|
110299-05-3
|
103G5E953K
|
Selodenoson
|
GWVQGVCXFNYGFP-PFHKOEEOSA-N
|
DB16326
| null |
Sepiapterin
|
17094-01-8
|
CJQ26KO7HP
|
L-sepiapterin | Sepiapterine
|
VPVOXUSPXFPWBN-VKHMYHEASA-N
|
DB16327
| null |
Sepofarsen
|
2227173-68-2
|
7CAZ46X8EL
|
Sepofarsen
| null |
DB16328
| null |
Seviprotimut-L
| null |
B061MTO20N
|
Human polyvalent shedded antigen vaccine | Seviprotimut L | Seviprotimut-L
| null |
DB16329
| null |
siG12D LODER
| null |
NNQ0PKZ9EV
|
Panc1 (krasgat) | SiG12D LODER
| null |
DB16330
| null |
Simurosertib
|
1330782-76-7
|
LST350G3XU
|
2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one | Simurosertib
|
XGVXKJKTISMIOW-ZDUSSCGKSA-N
|
DB16331
| null |
Siremadlin
|
1448867-41-1
|
0282IF4JC8
|
Siremadlin
|
AGBSXNCBIWWLHD-FQEVSTJZSA-N
|
DB16332
| null |
Sodelglitazar
|
447406-78-2
|
6G973E04VI
|
Sodelglitazar
|
ZUGQWAYOWCBWGM-UHFFFAOYSA-N
|
DB16333
| null |
Sonlicromanol
|
1541170-75-5
|
JCU3O35RDS
|
(S)-6-Hydroxy-2,5,7,8-Tetramethyl-N-((R)-Piperidin-3-Yl)Chroman-2-Carboxamide | KH-176 | KH176 | Sonlicromanol
|
LZYWLEPSQNXESC-KUHUBIRLSA-N
|
DB16334
| null |
STX-100
|
1439902-67-6
|
JD43Y6YF3N
|
Humanized monoclonal antibody against human integrin alphaVbeta6
| null |
DB16335
| null |
Sulopenem etzadroxil
|
1000296-70-7
|
492M3I304T
|
Sulopenem etzadroxil
|
NBPVNGWRLGHULH-CSOWVJSESA-N
|
DB16336
| null |
Tafolecimab
|
2225109-03-3
|
KV2ZKH0NIM
|
Immunoglobulin igg2, anti-(human proprotein convertase subtilisin/kexin type 9) (human monoclonal ibi306 .gamma.2-chain), disulfide with human monoclonal ibi306 .kappa.-chain, dimer | Tafolecimab
| null |
DB16337
| null |
Talditercept alfa
|
1580555-26-5
|
766C38JSAR
|
Adnectin, anti-(human growth differentiation factor 8) (synthetic clone prd-1474 fibronectin type iii tenth domain (10fn3)-based isoform | Bivalent Anti-Human Myostatin Adnectin-Igg1 | Bms-986089 (fully human anti-myostatin adnectin) | Immunoglobulin g1 (human fc fragment) fusion protein with peptide (synthetic 17-amino acid linker) fusion protein with adnectin, anti-(human growth differentiation factor 8) (human clone bms-986089 fibronectin tenth type iii domain-derived), dimer | Taldefgrobep alfa | Talditercept alfa
| null |
DB16338
| null |
Taniborbactam
|
1613267-49-4
|
8IGQ156Z07
|
Taniborbactam
|
PFZUWUXKQPRWAL-NOLJZWGESA-N
|
DB16339
| null |
ABX-196
|
1161877-58-2
|
SOI87F7GN2
| null |
VITDDUXZOHEQMU-BYSUZVQFSA-N
|
DB16340
| null |
Tetrafluoroborate
|
14874-70-5
|
4YCF3545OY
|
Borate(1-), tetrafluoro- | Fluoroborate | Tetrafluoroborate | Tetrafluoroborate (bf41-) | Tetrafluoroborate anion | Tetrafluoroborate ion | Tetrafluoroborate(1-)
|
ODGCEQLVLXJUCC-UHFFFAOYSA-N
|
DB16341
| null |
Tilsotolimod
|
1948266-37-2
|
G287IC9MH3
|
Tilsotolimod
| null |
DB16342
| null |
Trastuzumab duocarmazine
|
1642152-40-6
|
XCR2BZ80N7
|
Immunoglobulin g1-kappa, anti-(homo sapiens erbb2 (epidermal growth factor receptor 2, receptor tyrosineprotein kinase erbb-2, egfr2, her2, her-2, p185cerbb2, neu, cd340)), humanized monoclonal antibody conjugated to the pro-drug seco-duocarmycinhydroxyb | Trastuzumab duocarmazine
| null |
DB16343
| null |
Tropifexor
|
1383816-29-2
|
NMZ08KM76Z
|
Tropifexor
|
VYLOOGHLKSNNEK-PIIMJCKOSA-N
|
DB16344
| null |
Tulrampator
|
1038984-31-4
|
7633T9D4LN
|
Tulrampator
|
JHCFQXNWYDLBOG-UHFFFAOYSA-N
|
DB16345
| null |
Uracil C-13
|
35803-45-3
|
OZF8J4VAIK
|
13C-uracil | Uracil (2-13c) | Uracil 2c-13 | Uracil C-13, 2- | Uracil-(2-13c)
|
ISAKRJDGNUQOIC-AZXPZELESA-N
|
DB16346
| null |
Veliflapon
|
128253-31-6
|
JXH6X663L0
|
Veliflapon
|
ZEYYDOLCHFETHQ-JOCHJYFZSA-N
|
DB16347
| null |
Velsecorat
|
1196509-60-0
|
P30N0911C2
|
Velsecorat
|
ZZWJKLGCDHYVMB-XGBAOLAVSA-N
|
DB16348
| null |
Viagenpumatucel-L
| null |
13H90KC831
|
Gp96-igg1-fc fusion protein and hla-a1 expressing, irradiated ad-100 whole cell vaccine | Viagenpumatucel l | Viagenpumatucel-L
| null |
DB16349
| null |
Vicagrel
|
1314081-53-2
|
8A63K3TN0U
| null |
GNHHCBSBCDGWND-KRWDZBQOSA-N
|
DB16350
| null |
Vixarelimab
|
2243320-83-2
|
W25GO3A75W
|
Immunoglobulin g (234-proline,303-glutamine), anti-(human oncostatin m receptor subunit .beta.) (human monoclonal kpl-716 .gamma.-chain), disulfide with human monoclonal kpl-716 .lambda.-chain, dimer | Vixarelimab
| null |
DB16351
| null |
Volinanserin
|
139290-65-6
|
EW71EE171J
|
Volinanserin
|
HXTGXYRHXAGCFP-OAQYLSRUSA-N
|
DB16352
| null |
Vonlerolizumab
|
1638935-72-4
|
C78148TF1D
|
Immunoglobulin g1-kappa, anti-(homo sapiens tnfrsf4(tumor necrosis factor receptor (tnfr) superfamily member 4, act35, ox40, cd134)), humanized monoclonal antibody | Immunoglobulin g1-kappa, anti-(human tumor necrosis factor receptor superfamily member 4 (act35 antigen, ox40l receptor, cd134 antigen))humanized mouse monoclonal antibody: .gamma.1 heavy chain (1-447) (humanized mouse vh (homo sapiens ighv1-46*01 (81%) | Pogalizumab | Vonlerolizumab
| null |
DB16353
| null |
Razuprotafib
|
1008510-37-9
|
0WAX4UT396
|
Razuprotafib
|
KWJDHELCGJFUHW-SFTDATJTSA-N
|
DB16354
| null |
Avasopasem manganese
|
435327-40-5
|
EY1WA413UL
|
Avasopasem manganese
|
WXEMWBBXVXHEPU-NDOCQCNASA-L
|
DB16355
| null |
Sotrovimab
|
2423014-07-5
|
1MTK0BPN8V
|
Sotrovimab
| null |
DB16356
| null |
Anti-SARS-CoV-2 IgY
| null | null |
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY)
| null |
DB16357
| null |
BGB-DXP593
| null | null | null | null |
DB16358
| null |
MW33
| null | null | null | null |
DB16359
| null |
CSL324
| null |
IA9ALH5N8D
| null | null |
DB16360
| null |
Anti-SARS-CoV-2 immunoglobulin
| null |
VF62JD6WN3
|
Anti-Coronavirus immunoglobulin | Anti-COVID-19 hyperimmune globulin (human) | GC5131 | hIVIG | Human plasma-derived immune-globulin for Coronavirus | Hyperimmune immunoglobulin to SARS-CoV-2 | Immune-globulin for Coronavirus disease (COVID-19) | SARS-CoV-2 antibody-based IVIG | SARS-CoV-2 immunoglobulin
| null |
DB16361
| null |
Descartes-30
| null |
4P8TSC4FR8
|
Descartes 30
| null |
DB16362
| null |
Silver proteinate
|
9015-51-4
| null |
Argyrol | Proteinated silver | Silver protein
| null |
DB16363
| null |
PlasmaCord
| null | null |
Human umbilical cord and placental blood plasma
| null |
DB16364
| null |
Recombinant Human Thrombopoietin
| null |
E2E529W34D
|
rhTPO | rHuTPO
| null |
DB16365
| null |
Treamid
| null | null |
BDDA | Bisamide derivative of dicarboxylic acid | XC268BG
| null |
DB16366
| null |
Eflepedocokin alfa
| null |
ZQ9E6EX2JE
|
F-652 (RECOMBINANT FUSION PROTEIN CONSISTING OF TWO HUMAN INTERLEUKIN-22 (IL-22) MOLECULES LINKED TO AN IMMUNOGLOBULIN CONSTANT REGION (IGG2-FC)) | IL-22 DIMER F-652 | IL-22 fusion protein | RECOMBINANT HUMAN INTERLEUKIN-22 IGG2-FC
| null |
DB16367
| null |
Autologous peripheral blood-derived CD34+ cells
| null | null |
CD34+ Cells | CLBS119
| null |
DB16368
| null |
Anti-SARS-CoV-2 equine immunoglobulin fragments
| null | null |
Anti-SARS-CoV-2 equine immunoglobulin fragments F(ab')2 | INOSARS
| null |
DB16369
| null |
Matrix-M
| null |
YZ7P8Y8ECX
|
Matrix-M1 | Matrix-M1 Adjuvant
| null |
DB16370
| null |
Mezagitamab
|
2227490-52-8
|
0XMR8L9LOL
|
Anti-Cd38 monoclonal antibody TAK-079 | IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1 (2'-PHOSPHO-ADP-RIBOSYL CYCLASE, ANTIGENE CD38))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN HUMANIZED(1-453) (HOMO SAPIENS VH (IGHV3-23*01 (89%) (IGHD)-I | IMMUNOGLOBULIN G1, ANTI-(HUMAN CD38 ANTIGEN) (HUMAN MONOCLONAL AB79 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AB79 .LAMBDA.-CHAIN, DIMER | Mezagitamab
| null |
DB16371
| null |
Glofitamab
|
2229047-91-8
|
06P3KLK2J8
|
Anti-CD20/CD3 bispecific monoclonal antibody RO7082859 | Glofitamab
| null |
DB16372
| null |
Cobolimab
|
2022215-65-0
|
3K5H4TX2KP
|
Cobolimab
| null |
DB16373
| null |
Melrilimab
|
2222865-46-3
|
26C72EGQ3G
|
Melrilimab
| null |
DB16374
| null |
Telazorlimab
|
2126777-87-3
|
0CRN540O4R
|
Telazorlimab
| null |
DB16375
| null |
Felzartamab
|
2197112-39-1
|
3O9FA4XC02
|
Felzartamab
| null |
DB16376
| null |
Actoxumab
|
1245634-25-6
|
G3LU5LC5SX
|
Actoxumab
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.